After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

For her first performance, Lizzo wowed in a black leather plunging bodysuit paired with silver hot pants which highlighted her slimmed-down figure. The About Damn Time hitmaker finished her look with ...

The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...

When best friends AnnaLee Canario and Dacia Benjamin started taking weight loss drugs together they thought it would be an ...

Novo Nordisk announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE programme. REDEFINE 2 is a 68-week efficacy and safety trial investigating ...

Early-life gut microbes could play a key role in protecting against diabetes. A healthy start for a healthier future.

Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...

Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...

Dosing underway in INLIGHT trial of WVE-007 in obesity with clinical data expected in 2H 2025; enrollment complete in first single dose cohort Multi-dosing ongoing in 200 mg cohort of RestorAATion-2 ...

The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.

Although the telemedicine company displayed blistering growth and issued robust guidance, shares of Hims & Hers (NYSE: HIMS) ...

The active ingredient in Rybelsus and Ozempic, semaglutide, has shown effectiveness for weight loss in some people ... site of Medical News Today. The chart below outlines the typical dosage ...